{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:11:40Z","timestamp":1792987900866,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00223-020-00738-8","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T20:02:31Z","timestamp":1596398551000},"page":"524-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism"],"prefix":"10.1007","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-6677","authenticated-orcid":false,"given":"K.","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-4978","authenticated-orcid":false,"given":"R.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-8093","authenticated-orcid":false,"given":"H.","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"P.","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-4757","authenticated-orcid":false,"given":"B.","family":"Decallonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,2]]},"reference":[{"issue":"5","key":"738_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJMoa1103864","volume":"365","author":"KP Schlingmann","year":"2011","unstructured":"Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U et al (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365(5):410\u2013421","journal-title":"N Engl J Med"},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bone.2015.06.018","volume":"81","author":"M Cools","year":"2015","unstructured":"Cools M, Goemaere S, Baetens D, Raes A, Desloovere A, Kaufman JM et al (2015) Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: a cross-sectional study. Bone 81:89\u201396","journal-title":"Bone"},{"issue":"4","key":"738_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2215\/CJN.05360512","volume":"8","author":"G Nesterova","year":"2013","unstructured":"Nesterova G, Malicdan MC, Yasuda K, Sakaki T, Vilboux T, Ciccone C et al (2013) 1,25(OH)2D\u201324 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis. Clin J Am Soc Nephrol 8(4):649\u2013657","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"738_CR4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1210\/jc.2013-3802","volume":"99","author":"TP Jacobs","year":"2014","unstructured":"Jacobs TP, Kaufman M, Jones G, Kumar R, Schlingmann KP, Shapses S et al (2014) A lifetime of hypercalcemia and hypercalciuria finally explained. J Clin Endocrinol Metab 99(3):708\u2013712","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"738_CR5","first-page":"3121","volume":"27","author":"DT Keeffe","year":"2016","unstructured":"Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA (2016) Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int 27(3):3121\u20133125","journal-title":"Osteoporos Int"},{"issue":"3","key":"738_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1210\/jc.2012-2772","volume":"98","author":"D Vanderschueren","year":"2013","unstructured":"Vanderschueren D, Pye SR, O\u2019Neill TW, Lee DM, Jans I, Billen J et al (2013) Active vitamin D (1,25-Dihydroxyvitamin D) and Bone health in middle-aged and elderly men: the european male aging study (EMAS). J Clin Endocrinol Metab 98(3):995\u20131005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"738_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1373\/clinchem.2015.244459","volume":"62","author":"H Ketha","year":"2016","unstructured":"Ketha H, Kumar R, Singh RJ (2016) LC-MS\/MS for Identifying patients with CYP24A1 mutations. Clin Chem 62(1):236\u2013242","journal-title":"Clin Chem"},{"issue":"2","key":"738_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1515\/cclm-2019-0996","volume":"58","author":"E Cavalier","year":"2020","unstructured":"Cavalier E, Huyghebaert L, Rousselle O, Bekaert AC, Kovacs S, Vranken L et al (2020) Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clin Chem Lab Med 58(2):197\u2013201","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"738_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ki.2013.184","volume":"85","author":"A Helmuth","year":"2014","unstructured":"Helmuth A, Konrad M, Schlingmann KP, Pasch A (2014) Hypercalcemia in a 60-year-old male. Kidney Int 85(1):219\u2013221","journal-title":"Kidney Int"},{"issue":"1","key":"738_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.ajkd.2014.06.037","volume":"65","author":"ML Figueres","year":"2015","unstructured":"Figueres ML, Linglart A, Bienaime F, Allain-Launay E, Roussey-Kessler G, Ryckewaert A et al (2015) Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations. Am J Kidney Dis 65(1):122\u2013126","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"738_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ndt\/gft460","volume":"29","author":"G Colussi","year":"2014","unstructured":"Colussi G, Ganon L, Penco S, De Ferrari ME, Ravera F, Querques M et al (2014) Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. Nephrol Dial Transplant 29(3):636\u2013643","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"738_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ndt\/gfu400","volume":"30","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, Daenen K, Bammens B, Claes K, Meijers B, Naesens M et al (2015) Microscopic nephrocalcinosis in chronic kidney disease patients. Nephrol Dial Transplant 30(5):843\u2013848","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"738_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2016-1070","volume":"37","author":"PJ Tebben","year":"2016","unstructured":"Tebben PJ, Singh RJ, Kumar R (2016) Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37(5):521\u2013547","journal-title":"Endocr Rev"},{"issue":"3","key":"738_CR14","doi-asserted-by":"publisher","first-page":"E423","DOI":"10.1210\/jc.2011-1935","volume":"97","author":"PJ Tebben","year":"2012","unstructured":"Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, Foreman JW, Chelminski PR, Kumar R (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 97(3):E423\u2013E427","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"738_CR15","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/jbmr.3884","volume":"34","author":"R Bouillon","year":"2019","unstructured":"Bouillon R, Bikle D (2019) Vitamin D metabolism revised: fall of dogmas. J Bone Miner Res 34(11):1985\u20131992","journal-title":"J Bone Miner Res"},{"issue":"5","key":"738_CR16","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jc.2016-4048","volume":"102","author":"C Hawkes","year":"2017","unstructured":"Hawkes C, Dong L, Hakonarson H, Meyers KE, Thummel KE, Levine MA (2017) CYP3A4 Induction by rifampin: an alternative pathway for vitamin D inactivation in patients with CYP24A1 mutations. J Clin Endocrinol Metab 102(5):1440\u20131446","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"738_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ando.2016.03.002","volume":"77","author":"C Loyer","year":"2016","unstructured":"Loyer C, Leroy C, Molin A, Odou MF, Huglo D, Lion G et al (2016) Hyperparathyroidism complicating CYP24A1 mutations. Ann Endocrinol (Paris) 77(5):615\u2013619","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"738_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14(2):115\u2013125","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"738_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.path.2019.08.006","volume":"12","author":"J Guilmette","year":"2019","unstructured":"Guilmette J, Sadow PM (2019) Parathyroid pathology. Surg Pathol Clin 12(4):1007\u20131019","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"738_CR20","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1530\/EC-17-0283","volume":"7","author":"M Mizamtsidi","year":"2018","unstructured":"Mizamtsidi M, Nastos C, Mastorakos G, Dina R, Viassiliou I, Gazouli M et al (2018) Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks. Endocr Connect 7(2):R56\u201368","journal-title":"Endocr Connect"},{"issue":"2","key":"738_CR21","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-18-0304","volume":"26","author":"K Brewer","year":"2019","unstructured":"Brewer K, Costa-Guda J, Arnold A (2019) Molecular genetic insights into sporadic primary hyperparathyroidism. Endocr Relat Cancer 26(2):R53\u201372","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"738_CR22","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.2015-2132","volume":"100","author":"F Tassone","year":"2015","unstructured":"Tassone F, Guarnieri A, Castellano E, Baffoni C, Attanasio R, Borretta G (2015) Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100(8):3069\u20133073","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"738_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3906\/sag-1806-181","volume":"49","author":"M Caliskan","year":"2019","unstructured":"Caliskan M, Kizilg\u00fcl M, Beysel S, Ucan B, Akcan F, Takir M et al (2019) Factors associated with glomerular filtration rate variation in primary hyperparathyroidism after parathyroidectomy. Turk J Med Sci 49(1):295\u2013300","journal-title":"Turk J Med Sci"},{"issue":"6","key":"738_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","volume":"32","author":"S Minisola","year":"2018","unstructured":"Minisola S, Gianotti L, Bhadada S, Silverberg SJ (2018) Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32(6):791\u2013803","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"738_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11914-020-00574-7","volume":"18","author":"L Rejnmark","year":"2020","unstructured":"Rejnmark L, Ejlsmark-Svensson H (2020) Effects of PTH and PTH hypersecretion on bone: a clinical perspective. Curr Osteopors Rep 18(3):103\u2013114","journal-title":"Curr Osteopors Rep"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00738-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-020-00738-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00738-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T23:04:51Z","timestamp":1627859091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-020-00738-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00738-8","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,2]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This case report has been approved by the ethical committee of the University Hospitals Leuven.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}